This page shows the latest benralizumab news and features for those working in and with pharma, biotech and healthcare.
medicines such as Imfinzi and monoclonal antibody Fasenra (benralizumab).
AZ’s own interleukin-5 inhibitor (IL-5) Fasenra (benralizumab) is approved as an add-on maintenance treatment for eosinophilic asthma, while another IL-5 inhibitor from GlaxoSmithKline’s IL-5
as AstraZeneca’s asthma injection Fasenra(benralizumab).
GSK is trying to keep the first-to-market IL-5 inhibitor ahead of other drugs in the class, particularly AstraZeneca’s Fasenra (benralizumab) which is gaining ground fast with
The company also received a positive opinion for a new self-administration option for Fasenra (benralizumab) via a pre-filled, single-use auto-injector, rivalling similar moves from GSK and its
Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab).
More from news
Approximately 8 fully matching, plus 43 partially matching documents found.
In order to focus its respiratory resources on products such as Symbicort and benralizumab, AstraZeneca has agreed that its product Tudorza (marketed for COPD) and Duaklir (in phase III for COPD)
In Japan, AZ paid $45m for an option with Kyowa Hakko Kirin to commercialise benralizumab (currently in phase III for treatment of severe uncontrolled asthma and COPD) in Japan.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
No results were found
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...